DRIVING

Innovation in

Synthetic and Biotech
(Fermentation) APIs

We’re

A research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across three platforms:

Organic Chemistry
Biotechnology
Complex Injectables

Agile Tech Adoption

Demonstrating agility by rapidly embracing technologies such as biotransformation, precision fermentation, double chamber platforms, continuous flow chemistry and integrating them into our manufacturing processes, which we believe has enabled us to bring complex products to the market

We have a global leadership position in Corticosteroid and Steroidal-Hormone Active Pharmaceutical Ingredients ("APIs") in volume terms in Fiscal 2025.

READ MORE...

Events Connect with us at Global Pharmaceutical Exhibitions and Conferences
Background Video Overlay
Content
Global Presence

Global Steroid APIs Excellence

We are the only Indian and global company to have a presence across the top 10 Corticosteroid and Steroidal-Hormone APIs in Fiscal 2025, demonstrating the depth of our portfolio

Corticosteroid APIs

Steroidal-Hormone APIs

Manufactures these products using fermentation and multi-step complex chemical reactions

Built on Experience

Over 30 years of industry experience, we have evolved from a lab-scale Steroidal-Hormone API manufacturer in 1995 into an industrial-scale, Symbiotec is one of the first generics companies globally to successfully develop DCV through backward integration, by relying on in-house materials and not imports, for

Methylprednisolone Sodium Succinate Injection and
Hydrocortisone Sodium Succinate Injection

With approvals from
WHO GMP
WHO-GMP World Health Organization Good Manufacturing Practices
US FDA
US FDA United States Food and Drug Administration
EU GMP
EU-GMP European Union Good Manufacturing Practices
MFDS Korea
MFDS Korea Ministry of Food and Drug Safety, Korea and Other Global Organizations

Offerings Integrated CDMO Solutions Across
Chemistry, Biotechnology & Injectables

Leveraging our deep capabilities across Organic Chemistry, Biotechnology, and Complex Injectables to operate as a Contract Development and Manufacturing Organization (“CDMO”), variably for specialty Pharmaceutical and Nutraceutical companies globally, offering products and services across the three platforms in which we also manufacture our own products

Infrastructure

Operational Manufacturing Locations

Rau Facility (Rau Unit) — Established in 2004, dedicated facilities for Cortico-Steroid API Manufacturing

Pithampur Facility (SEZ Unit) — Established in 2010, with dedicated facilities for Cortico-Steroid API, Hormone API, and Fermentation & Biotransformation

SEZ Facility
RAU Facility

What’s New

Classical Fermentation-Based APIs We have already launched Fermentation-Based APIs such as Mupirocin, Teicoplanin and Serratiopeptidase, among others, and we intend to build on this foundation by introducing additional High-Value, low-volume APIs in niche therapeutic areas
Speciality Ingredients Such as Vegan Vitamin D3 and Algal based Docosa Hexanoic Acid (DHA)
CDMO Services for Food/Nutraceuticals such as alternative Protein and Enzymes, and Industrial Biotechnology Products
Complex Injectable Formulation One of the first generics globally to develop DCV (Double Chamber Vials) through backward integration
Regulatory Compliance

Accreditations

Rau Facility

  • US– FDA
  • EU GMP – Germany Bavaria
  • WHO GMP
  • USFDA – Facility Establishment Identification (FEI): 3005122933
  • D-U-N-S Number: 650328805

Pithampur Facility

  • US– FDA
  • EU GMP – Germany Bavaria
  • WHO GMP
  • USFDA – Facility Establishment Identification (FEI): 3009298759
  • D-U-N-S Number: 677604336
ISO
TÜV NORD CERT GmbH

Environment Management
System [EMS]

ISO 14001:2015 (SEZ & RAU Sites)
44 104 21393400
30.11.2024
29.11.2027
Download
ISO
TÜV NORD CERT GmbH

Occupational Health & Safety
[OHSMS]

ISO 45001:2018 (SEZ & RAU Sites)
44 126 21393400
30.11.2024
29.11.2027
Download
Production Facility
Corticosteroid APIs
Steroid-Hormone APIs

Offers a robust product portfolio of over 60 Corticosteroid and Steroid-Hormone APIs

According to F&S Report in molecules such as Hydrocortisone, Testosterone, and Methylprednisolone, we held a Global Leadership Position

Fiscal 2025 Market Share

Capturing over 50% Market share of supply by volume

Performance Indicators

Differentiators

Scale, science, and global reach reflect the strength of our integrated manufacturing platform — reinforcing our dedication to quality, innovation, and long-term partnerships

200+ Customers

Serving strategic accounts across >40 countries with precision

1,700+

Strong and diversely skilled global workforce

138 Experts

High-caliber scientists and engineers fueling R&D innovation

Backward Integration

Advanced supply chain control from fermentation to synthesis

584.67 MT

Total aggregate chemical synthesis capacity

700 KL

Substantial industrial fermentation capacity

Global Accreditations

Accredited by renowned global regulatory authorities for excellence in quality

Sustainability at Symbiotec

Integral to our business philosophy and decision-making process

Download Report